Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
10/09/2025 13:11
Sept 10 (Reuters) - LakeShore Biopharma Co Ltd H6Z0.F: LAKESHORE BIOPHARMA ANNOUNCES APPOINTMENT OF INDEPENDENT FINANCIAL ADVISOR AND LEGAL COUNSEL TO THE SPECIAL COMMITTEE LAKESHORE BIOPHARMA CO LTD - SPECIAL COMMITTEE CONTINUES REVIEW OF PROPOSAL Source text: ID:nPn8tKlX6a Further company coverage: H6Z0.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing